- Telehealth Visits
- Insurance plan information
Alyssa Nylander, MD, PhD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information
Alyssa Nylander, MD, PhD
Neurology • Neuroimmunology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Neurology, American Board of Psychiatry/Neurology-Neurology
Residency
- Neurology, UCSF Graduate Medical Education
Internship
- Internal Medicine, UCSF Graduate Medical Education
Degree
- MD, Yale University School of Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222901%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222901%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 21 reviews
- January 6, 20265 out of 5 Stars
Dr Nylander covered all issues
- December 5, 20255 out of 5 Stars
I am a complicated case. Dr. Nylander has taken the time to listen, understand, and respond. Consequently, I look to her for medical guidance
- December 4, 20255 out of 5 Stars
All I can say is "wow"! This doctor was great. She was very professional and nice. I felt better after talking with her. I recommend her to people.
- November 21, 20255 out of 5 Stars
This was my first visit with Dr Nylander and she was wonderful. Took time to go over my MRI results, discussed my options and put a plan together moving forward. I can't ask for much more than that!
- November 8, 20255 out of 5 Stars
The Dr was amazing
- September 26, 20255 out of 5 Stars
Dr Nylander is a wonderful listener and works collaboratively with me
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.